2020. Molecular-Docking Study of quinazolin-4(3H)-one derivatives against GABAa Receptor Signifies the Novel Approach to Epilepsy Treatment. International Journal of Pharmaceutical Sciences and Drug Research. 12, 5 (Sep. 2020), 572–575. DOI:https://doi.org/10.25004/IJPSDR.2020.120521.